Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as GBX 1.57 ($0.02) and last traded at GBX 1.70 ($0.02), with a volume of 3418268 shares changing hands. The stock had previously closed at GBX 1.70 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market cap of £6.74 million, a price-to-earnings ratio of 170.00 and a beta of 0.35. The firm has a 50 day moving average price of GBX 1.95 and a 200-day moving average price of GBX 2.11.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- High Flyers: 3 Natural Gas Stocks for March 2022
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Stock Splits, Do They Really Impact Investors?
- Generac Powers Ahead on the Electrification Mega-Trend
- Energy and Oil Stocks Explained
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
